Arca
Skip to content

Scanning Laserlink

Laser, Ophthalmic. 510(k) K130195, from Lumenis, Inc. (Salt Lake City, UT). Product code HQF, class 2.

As of Nov 17, 2026, K130195 is an FDA 510(k) held by Lumenis, Inc., substantially equivalent on Nov 1, 2013 after 277 days, with 1 recall tied to it in FDA's recall database.

  • Substantially equivalent: Nov 1, 2013
  • Review time: 277 days
  • Recalls: 1

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Recalls

Recalls FDA ties to K130195, newest first; each opens FDA's recall record
StartedReasonStatus
Aug 15, 2014Z-2733-2014Lumenis initiated a field-correction for the Array Laser Link", GA-0006700 (SN XXYYZZ) because the system may project an erroneous pattern display on the retina, which is different than the desired pattern.Terminated

Other HQF Clearances

The newest 510(k)s for the same product code; their median review was 264 days; see every HQF device

Record

Type
Abbreviated
Received
Jan 28, 2013
Review panel
Ophthalmic
Regulation
21 CFR 886.4390

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.